Senior insider sale
Chief Medical Officer at REVOLUTION MEDICINES, INC. — senior position signals high conviction
$227.9K
2.29K shares
What this filing means
WEI LIN plans to sell 2.29K shares of REVOLUTION MEDICINES, INC. valued at approximately $227.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/13/2026ACC: 0001872772-26-000002
Officer· Chief Medical Officer
Since Mar 2026
2.29K
Shares to sell
$227.9K
Approx. market value
2.29K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months3
Restricted stock unit grant
Services Rendered
3/1/2025
517.00Restricted stock unit grant
Services Rendered
3/1/2024
464.00Restricted stock unit grant
Services Rendered
5/1/2023
1.31KTotal acquired2.29K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/1/2025 | Restricted stock unit grant Services Rendered | 517.00 | — |
3/1/2024 | Restricted stock unit grant Services Rendered | 464.00 | — |
5/1/2023 | Restricted stock unit grant Services Rendered | 1.31K | — |
| Total | 2.29K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
2.29K
Market value
$227.9K
3/16/2026
Total
Units
2.29K
Value
$227.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/16/2026 | 2.29K | $227.9K | NASDAQ | Planned |
| Total | 2.29K | $227.9K | ||